Invited Speakers: GUEST FACULTY
Margaret E. Daube-Witherspoon, Ph.D.
Physicist, Positron Emission Tomography Department
National Institutes of Health
David M. Goldenberg, ScD., M.D.
President, Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Eric P. Krenning, M.D., Ph.D.
Professor of Nuclear Medicine Erasmus University
Head, Department of Nuclear Medicine
University Hospital Rotterdam
David E. Kuhl, M.D.
Professor of Internal Medicine and Radiology
Chief, Division of Nuclear Medicine
University of Michigan Medical Center
Joseph A. Kuhn, M.D.
Assistant Director of Surgical Education
Baylor University Medical Center
David A. Mankoff, M.D., Ph.D.
Assistant Professor of Radiology
University of Washington Medical Center
Ronald D. Neumann, M.D.
Chief, Department of Nuclear Medicine
National Institutes of Health
David R. Piwnica-Worms, M.D., Ph.D.
Associate Professor of Radiology, Molecular Biology and Pharmacology
Washington University School of Medicine
Paul D. Shreve, M.D.
Assistant Professor of Internal Medicine
Division of Nuclear Medicine
University of Michigan Medical Center and VA Medical Center
Peter E. Valk, M.D.
Medical Director
Northern California PET Imaging Center
Richard L. Wahl, M.D.
Professor of Internal Medicine and Radiology
Director of General Nuclear Imaging
University of Michigan
Program:
Nuclear Medicine is the medical specialty best suited to translate the exploding body of knowledge obtained from research in genetics and molecular biology into the care of patients. This fourth annual nuclear oncology conference will address how this can be done and how positron emission tomography (PET) and single photon emission tomography (SPECT) can be used in the care of patients with cancer or with increased genetic risk of developing cancer. The course will include illustrative patient studies showing how PET and SPECT can help in diagnosis, staging and treatment planning and monitoring of patients with cancer.
Registrants will learn:
1.) How PET and SPECT can help detect the first signs of disease in patients with cancer or with increased genetic risk of cancer.
2.) How PET and SPECT studies help in the care of patients with cancer.
3.) How to use PET/SPECT imaging in the light of the patient's clinical problems.
Registration :
Deadline for Abstracts: tba
Email for Requests and Registration: cmenet@som.adm.jhu.edu